Tag: infusion

SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it will present preclinical data on the RaniPill® capsule at the Endocrine Society’s Annual Meeting (ENDO 2025) taking place July 12-15 in San Francisco, CA.

VANCOUVER, British Columbia, July 12, 2025 (GLOBE NEWSWIRE) -- Canada-based and Solana-focused FinFra leader Astra Fintech today reinforced its commitment to the Solana ecosystem by announcing a $10M strategic acquisition of Dexlab, a pioneering Solana-native token launching and tooling platform. Backed by Astra’s recently launched $100 million Solana ecosystem fund, this deal marks a bold step in the company’s mission to accelerate PayFi adoption across Asia and beyond.

Complete Response Letter (CRL) cited specific chemistry, manufacturing and controls (CMC) related observations that are resolvable

BALI, Indonesia, July 10, 2025 (GLOBE NEWSWIRE) -- Global Recognition Awards™ has honored Viceroy Bali with a 2025 Global Recognition Award for Bali’s Best Luxury Resort, celebrating the property’s outstanding achievements in luxury hospitality and its ongoing commitment to excellence in the industry. The award recognizes the resort's exceptional standards in luxury hospitality, following its previous recognition as the World's #1 Resort by Condé Nast Traveler in 2018 and multiple World Luxury Hotel Awards, including Best Luxury Honeymoon Resort Worldwide in 2024.

GAITHERSBURG, Md., July 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification has been secured to deliver CNJ-016^® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) to the Administration for Strategic Preparedness and Response (ASPR), part of the U. S. Department of Health and Human Services (HHS), for smallpox preparedness. ASPR exercised an option from its existing 10-year contract (75A50119C00037) for additional doses of VIGIV, a treatment for complications due to smallpox vaccination.